Exclusive: mRNA startup Turn Biotechnologies acquires Vesigen’s microvesicle delivery tech

Turn Biotechnologies acquires drug delivery tech from Harvard & Vesigen Therapeutics to expand mRNA aging therapies; CEO Anja Krammer aims for 2026 clinical trialsRead More

What's Trending

Global Capability Center Gets a New Purpose, People and Performance Roadmap for Success, Announced by ANSR

GOP Senate hopeful John Deaton on Mass. policy debates and global tensions

Trump To Propose Tech Giants Fund Power Grid Buildouts, Energy Stocks Swing

Wildfire victims decry state law protecting utilities from cost of disasters they cause

WA law enforcement association considers expelling Pierce County sheriff

New tortilla law

Mamdani Warns Delivery Apps to Follow New Worker Protection Laws — Or Else – Streetsblog New York City

Michael A. Gross, Michael Gross Law Office

Exclusive: mRNA startup Turn Biotechnologies acquires Vesigen’s microvesicle delivery tech

Trump To Propose Tech Giants Fund Power Grid Buildouts, Energy Stocks Swing

Diabetes Dialogue: Tech Updates on Twiist, MiniMed Go, and More

Trump Moves to Make Tech Giants Pay for Surging Power Costs

Escaping the trap of US tech dependence

Leave A Reply Cancel Reply

What's Trending

Exclusive: mRNA startup Turn Biotechnologies acquires Vesigen’s microvesicle delivery tech

Related Posts

Leave A Reply Cancel Reply

Subscribe to MGSN